Lyra Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Provided By GlobeNewswire
Last update: Aug 14, 2024
– Primary focus continues to be on upcoming results from ENLIGHTEN 1 Phase 3 extension study in 4Q 2024 and ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients in 1H 2025, as planned –
15.5
-2.91 (-15.83%)
Find more stocks in the Stock Screener
LYRA Latest News and Analysis
2 days ago - ChartmillLet's have a look at the top gainers and losers in the middle of the day of today's session.Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
8 days ago - ChartmillWhat's going on in today's sessionStay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
8 days ago - ChartmillWhich stocks are moving on Tuesday?Curious about what's happening in today's session? Check out the latest stock movements and price changes.
